The Future Use of Complex Biomarkers

preview_player
Показать описание
This video is of Friends of Cancer Research's first-ever virtual symposium, "The Future Use of Complex Biomarkers" that took place on July 14, 2020. In this video, there is an explainer of TMB, or tumor mutational burden, a fireside chat between Dr. Richard Pazdur, FDA; Dr. Elizabeth Jaffee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and Dr. Eric Rubin, Merck. There is also a panel discussion with Dr. Brian Alexander, Foundation Medicine; Dr. Matthew Hellmann, Memorial Sloan Kettering Cancer Center; Dr. Jamie Holloways, Caris Life Sciences; Dr. Steven Lemery, FDA; and moderated by Sarah Karlin-Smith, The Pink Sheet.

00:00 - Meeting Begins
04:19 - Fireside Chat with Drs. Elizabeth Jaffee, Richard Pazdur, and Eric Rubin
22:30 - Panel Discussion with Sarah Karlin-Smith, Brian Alexander, Matthew Hellmann, Jamie Holloway, and Steven Lemery
Рекомендации по теме
Комментарии
Автор

great talk, where can I find the 2nd part?

itaigutman